APA

Morsy H., Taha E. A., Nigm D. A., Shahin R. & Youssef E. M. K. (20180523). Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity. : Clinical and experimental dermatology.

Chicago

Morsy H, Taha E A, Nigm D A, Shahin R and Youssef E M K. 20180523. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity. : Clinical and experimental dermatology.

Harvard

Morsy H., Taha E. A., Nigm D. A., Shahin R. and Youssef E. M. K. (20180523). Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity. : Clinical and experimental dermatology.

MLA

Morsy H, Taha E A, Nigm D A, Shahin R and Youssef E M K. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity. : Clinical and experimental dermatology. 20180523.